Web of Science: 6 citas, Scopus: 6 citas, Google Scholar: citas,
Review and statistical analysis of clinical management of feline leishmaniosis caused by Leishmania infantum
Garcia-Torres, Maria (Universitat Autònoma de Barcelona. Hospital Clínic Veterinari)
López, Maria Cristina (Universitat Autònoma de Barcelona. Hospital Clínic Veterinari)
Tasker, Séverine (Linnaeus Veterinary Limited)
Lappin, Michael R (Colorado State University. Department of Clinical Sciences)
Blasi Brugué, Carles (Universitat Autònoma de Barcelona. Hospital Clínic Veterinari)
Roura, Xavier (Universitat Autònoma de Barcelona. Hospital Clínic Veterinari)

Fecha: 2022
Resumen: There is limited information about feline leishmaniosis (FeL) management in clinical practice. Leishmania infantum is the species of Leishmania most frequently reported in both dogs and cats in countries of the Mediterranean region (henceforth 'Mediterranean countries'), Central and South America, and Iran. This study was conducted to provide veterinary clinicians with an updated overview of evidence-based information on leishmaniosis in cats. A review was performed using PubMed, Science Direct, Google Scholar and Web of Science. Case reports of FeL caused by L. infantum were sought for the period 1912 to 1 June 2021. Sixty-three case reports are included in this review. Fifty-nine out of the 63 cats were from Europe, mostly from Mediterranean countries (88. 9%). Most of them were domestic short-haired cats (90%) with a mean age of 7. 9 years, and had access to the outdoors (77. 3%). Sixty-six percent of the cats had comorbidities, of which feline immunodeficiency virus infection was the most frequent (37. 7%). Dermatological lesions (69. 8%) was the most frequent clinical sign, and hyperproteinemia (46. 3%) the most frequent clinicopathological abnormality. Serology was the most performed diagnostic method (76. 2%) and was positive for 93. 7% of cats. Medical treatment was applied in 71. 4% of cats, and allopurinol was the most used drug (74. 4%). Survival time was greater for treated cats (520 days; 71. 4% of cats) than non-treated cats (210 days; 25. 4%). The majority of the cats had comorbidities, of which feline immunodeficiency virus was the most frequent. Dermatological lesions were frequently reported, and systemic clinical signs and clinicopathological abnormalities were also common. Serology may be useful for the diagnosis of FeL in clinical practice, and a positive titer of ≥ 1/40 may be a useful cut-off for sick cats. The reported treatments and dosages varied, but there was a good clinical response and longer survival in most of the cats treated with allopurinol monotherapy.
Derechos: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. Creative Commons
Lengua: Anglès
Documento: Article ; recerca ; Versió publicada
Materia: Cats ; Leishmaniasis ; Serology ; Allopurinol ; Practitioners
Publicado en: Parasites & vectors, Vol. 15 (july 2022) , ISSN 1756-3305

DOI: 10.1186/s13071-022-05369-6
PMID: 35818075


13 p, 992.3 KB

El registro aparece en las colecciones:
Documentos de investigación > Documentos de los grupos de investigación de la UAB > Centros y grupos de investigación (producción científica) > Ciencias de la salud y biociencias > Grup de Recerca Malalties infeccioses-inflamatòries en animals de companyia (MIAC)
Artículos > Artículos de investigación
Artículos > Artículos publicados

 Registro creado el 2022-12-14, última modificación el 2023-11-07



   Favorit i Compartir